Edward Meinert is a Sir David Cooksey Fellow in Healthcare Translation. This fellowship is focused on bridging two major gaps in healthcare translation. Firstly, to support deep academic research into non-laboratory biomedical research, including technology development, regulation, intellectual property, clinical adoption and biomanufacturing - areas that currently receive limited support from traditional grant-making organisations. Secondly, to sustainably support the training and development of future translational academic and industry leaders, to ensure that the appropriate skills are available to support biomedical innovations globally across the "Valley of Death".
Edward is a member of the Healthcare Translation Research Group, whose focus is on high-impact research in regenerative medicine (cell, gene, immuno-therapies and tissue engineering) and e-health – including medicines optimisation and supply chain security.
Edward read Software Engineering and Business Administration at the University of Oxford (Exeter College), Theology and Religous Studies at the University of Cambridge (Hughes Hall), Public Administration at the London School of Economics and Clinical Medicine Research at Imperial College London under the supervision of Associate Professor Josip Car and Professor Azeem Majeed. Edward is a Chartered Engineer (Engineering Council), a Fellow of the British Computer Society and a Fellow of the Chartered Management Institute.
Sir David Cooksey Fellowship in Healthcare Translation
THE DESIGN, DEVELOPMENT AND EVALUATION OF DIGITAL HEALTH SOLUTIONS TO IMPACT ANALYSIS AND INSIGHT OF HEALTHCARE DATA
Edward Meinert is a Chartered Engineer specialising in digital strategy and software engineering. Edward's research is centred on the use of digital technology in medicine. His primary research interests include robotic process automation in digital health systems and software application development for enhancement of data collection and information dissemination, with a primary aim to improve cost, impact on analytics and adoption. He is particularly interested in applications to novel regulatory and therapeutic contexts, such as adaptive and long-term trials focused on preventive medicine, where there are significant opportunities to derive insight from improved data analytics and where standards are yet to be established.
The use of health information technologies (HITs) has been associated with positive benefits such as improved health outcomes and enhanced health services. Results from empirical studies report potential benefits of HITs in preventive medicine measures such as primary prevention. While there are significant efforts underway to establish frameworks to manage digital services, there is much work required to determine how these technologies can be used to improve health outcomes sustainably. Edward aims to develop evidence to inform improvement in the design of technologies and to influence policy to promote adoption of these systems.
European Institute for Innovation and Technology (EIT) Health, Higher Education Funding Council for England (HEFCE), NHS England, European Institute for Innovation and Technology (EIT) Digital
Digital Education in Health Professions: The Need for Overarching Evidence Synthesis
Car J. et al, (2019), Journal of Medical Internet Research
A Multistep Research Protocol to Develop and Implement Validated Guidelines for CMO RFI and RFP Processes: Biopharmaceutical Vendor Evaluation and Selection Minimum Standards (BioVesel)
BRINDLEY D. et al, (2018), BioProcess international
Biotechnology Governance 2.0: A Proposal for Minimum Standards in Biotechnology Corporate Governance.
Carter A. et al, (2018), Rejuvenation research
Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.
Brindley D. et al, (2018), Rejuvenation research
How standards and user involvement can improve app quality: A lifecycle approach
Van Velthoven MH. et al, (2018), International Journal of Medical Informatics, 118, 54 - 57